Dynamics of antigen-specific regulatory T-cells in the context of autoimmunity

Seminars in Immunology

Volumn 19, Issue 4, 2007, Pages 272-278

  Korn, Thomas ^a   Oukka, Mohamed ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Foxp3; MHC class II tetramer; Regulatory T cell

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN SPECIFICITY; AUTOIMMUNITY; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; REGULATORY T LYMPHOCYTE; REPORTER GENE; REVIEW;

ANIMALS; ANTIGENS; AUTOIMMUNITY; FORKHEAD TRANSCRIPTION FACTORS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY;

EID: 34447283057     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.03.001     Document Type: Review

References (63)

1. Fowlkes B.J., and Ramsdell F. T-cell tolerance. Curr Opin Immunol 5 (1993) 873-879
2. Walker L.S., and Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2 (2002) 11-19
3. Seddon B., and Mason D. The third function of the thymus. Immunol Today 21 (2000) 95-99
4. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184 (1996) 387-396
5. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
6. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
7. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
8. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., and Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445 (2007) 936-940
9. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445 (2007) 931-935
10. Kim J.M., and Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 212 (2006) 86-98
11. Lahl K., Loddenkemper C., Drouin C., Freyer J., Arnason J., Eberl G., et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204 (2007) 57-63
12. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
13. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 (2001) 18-20
14. Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage?. Immunity 19 (2003) 165-168
15. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y., et al. T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
16. Tai X., Cowan M., Feigenbaum L., and Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6 (2005) 152-162
17. Marie J.C., Letterio J.J., Gavin M., and Rudensky A.Y. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201 (2005) 1061-1067
18. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
19. Le Douarin N., Corbel C., Bandeira A., Thomas-Vaslin V., Modigliani Y., Coutinho A., et al. Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol Rev 149 (1996) 35-53
20. Ribot J., Romagnoli P., and van Meerwijk J.P. Agonist ligands expressed by thymic epithelium enhance positive selection of regulatory T lymphocytes from precursors with a normally diverse TCR repertoire. J Immunol 177 (2006) 1101-1107
21. Chen Z., Benoist C., and Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci USA 102 (2005) 14735-14740
22. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., and Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immunol 7 (2006) 401-410
23. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
24. Lin W., Haribhai D., Relland L., Truong N., Carlson M., Williams C., et al. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 8 (2007) 359-368
25. Williams L.M., and Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 8 (2007) 277-284
26. Hsieh C.S., Liang Y., Tyznik A.J., Self S.G., Liggitt D., and Rudensky A.Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21 (2004) 267-277
27. Pacholczyk R., Ignatowicz H., Kraj P., and Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25 (2006) 249-259
28. Mills K.H. Regulatory T cells: friend or foe in immunity to infection?. Nat Rev Immunol 4 (2004) 841-855
29. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., and Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
30. Lafaille J.J., Nagashima K., Katsuki M., and Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78 (1994) 399-408
31. Hori S., Haury M., Coutinho A., and Demengeot J. Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 99 (2002) 8213-8218
32. Stephens L.A., Gray D., and Anderton S.M. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc Natl Acad Sci USA 102 (2005) 17418-17423
33. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 16 (2004) 249-256
34. Reddy J., Illes Z., Zhang X., Encinas J., Pyrdol J., Nicholson L., et al. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 101 (2004) 15434-15439
35. Tarbell K.V., Yamazaki S., Olson K., Toy P., and Steinman R.M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 199 (2004) 1467-1477
36. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7 (2006) 83-92
37. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13 (2007) 423-431
38. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
39. Liang S., Alard P., Zhao Y., Parnell S., Clark S.L., and Kosiewicz M.M. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 201 (2005) 127-137
40. Apostolou I., and von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199 (2004) 1401-1408
41. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711
42. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6 (2005) 1219-1227
43. Suffia I.J., Reckling S.K., Piccirillo C.A., Goldszmid R.S., and Belkaid Y. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203 (2006) 777-788
44. Kohm A.P., Carpentier P.A., Anger H.A., and Miller S.D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169 (2002) 4712-4716
45. Tischner D., Weishaupt A., van den B.J., Muller N., Beyersdorf N., Ip C.W., et al. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. Brain 129 (2006) 2635-2647
46. Lee I., Wang L., Wells A.D., Dorf M.E., Ozkaynak E., and Hancock W.W. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 201 (2005) 1037-1044
47. Yurchenko E., Tritt M., Hay V., Shevach E.M., Belkaid Y., and Piccirillo C.A. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med 203 (2006) 2451-2460
48. Kleinewietfeld M., Puentes F., Borsellino G., Battistini L., Rotzschke O., and Falk K. CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. Blood 105 (2005) 2877-2886
49. Suffia I., Reckling S.K., Salay G., and Belkaid Y. A role for CD103 in the retention of CD4+CD25+ T reg and control of Leishmania major infection. J Immunol 174 (2005) 5444-5455
50. Wan Y.Y., and Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445 (2007) 766-770
51. van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., and Taams L.S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50 (2004) 2775-2785
52. Cao D., Borjesson O., Larsson P., Rudin A., Gunnarsson I., Klareskog L., et al. FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints. Scand J Immunol 63 (2006) 444-452
53. Ruprecht C.R., Gattorno M., Ferlito F., Gregorio A., Martini A., Lanzavecchia A., et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201 (2005) 1793-1803
54. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240
55. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
56. Pasare C., and Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299 (2003) 1033-1036
57. Oberg H.H., Wesch D., Grussel S., Rose-John S., and Kabelitz D. Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25 high regulatory T cells. Int Immunol 18 (2006) 555-563
58. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
59. Hirota K., Hashimoto M., Yoshitomi H., Tanaka S., Nomura T., Yamaguchi T., et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204 (2007) 41-47
60. Peng Y., Laouar Y., Li M.O., Green E.A., and Flavell R.A. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci USA 101 (2004) 4572-4577
61. Chen Z., Herman A.E., Matos M., Mathis D., and Benoist C. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 202 (2005) 1387-1397
62. McGeachy M.J., Stephens L.A., and Anderton S.M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 175 (2005) 3025-3032
63. Tadokoro C.E., Shakhar G., Shen S., Ding Y., Lino A.C., Maraver A., et al. T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med 203 (2006) 505-511